There’s an interesting article in this months edition of iam-magazine in which Joff Wild interviews David Kappos (VP IP law at IBM) about a proposed new type of patent right which...
A brilliant but shy reader of this blog, who is General Counsel at a well known international company passed this news on to me last week. Just over a month ago...
Thanks to Patent Docs blog for pointing out that on Monday this week Nucleonics sought en banc review of the CAFC decision which held that it no longer had standing to...
On Monday 6 August Novartis suffered a blow in its battle to obtain Indian patent protection for its beta crystalline form of Glivec (Imatinib mesylate). The case has attracted a lot...
Yesterday Novartis suffered a blow in its battle to obtain Indian patent protection for its beta crystalline form of Glivec (Imatinib mesylate). The case has attracted a lot of attention (a)...
In this article, “Australia even more patent-friendly after High Court decision” in the August/September 2007 edition of IAM-Magazine, I explain why patentees or licensees of Australian patents can be more bullish...
In this article in the August/September 2007 edition of IAM-Magazine, I explain why patentees or licensees of Australian patents can be more bullish about asserting them as they now have less...
Tarun Mathur’s report on Patent Litigation Trends in India has some interesting findings, including: although the number of patents filed in India is continuing to grow, the number of decided patent...
A recent Patent Baristas post (Gilead Sciences Pwned by Nonprofit Activists) discusses Tenofovir (an HIV / AIDs drug) and the success that the not-for-profit Public Patent Foundation has recently had in...
Russia and the USA came first and second in IPKat’s recent poll asking readers to nominate the country in which they would least like to litigate an IP case. (China came...
You must be logged in to post a comment.